PL1855692T3 - Kompozycje do leczenia chorób skóry charakteryzujących się wysiękiem białek surowicy - Google Patents

Kompozycje do leczenia chorób skóry charakteryzujących się wysiękiem białek surowicy

Info

Publication number
PL1855692T3
PL1855692T3 PL06716088T PL06716088T PL1855692T3 PL 1855692 T3 PL1855692 T3 PL 1855692T3 PL 06716088 T PL06716088 T PL 06716088T PL 06716088 T PL06716088 T PL 06716088T PL 1855692 T3 PL1855692 T3 PL 1855692T3
Authority
PL
Poland
Prior art keywords
exudation
serum proteins
compositions
skin diseases
treating skin
Prior art date
Application number
PL06716088T
Other languages
English (en)
Inventor
Seong-Hyun Choi
Original Assignee
Choi Seong Hyun
Kt & G Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choi Seong Hyun, Kt & G Corp filed Critical Choi Seong Hyun
Publication of PL1855692T3 publication Critical patent/PL1855692T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A44HABERDASHERY; JEWELLERY
    • A44CPERSONAL ADORNMENTS, e.g. JEWELLERY; COINS
    • A44C15/00Other forms of jewellery
    • A44C15/0045Jewellery specially adapted to be worn on a specific part of the body not fully provided for in groups A44C1/00 - A44C9/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A44HABERDASHERY; JEWELLERY
    • A44CPERSONAL ADORNMENTS, e.g. JEWELLERY; COINS
    • A44C25/00Miscellaneous fancy ware for personal wear, e.g. pendants, crosses, crucifixes, charms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
PL06716088T 2005-02-28 2006-02-23 Kompozycje do leczenia chorób skóry charakteryzujących się wysiękiem białek surowicy PL1855692T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020050016567A KR100891595B1 (ko) 2005-02-28 2005-02-28 혈액 단백질의 삼출을 감소시키는 조성물
PCT/KR2006/000638 WO2006091033A1 (en) 2005-02-28 2006-02-23 Composition for reducing the exudation of serum proteins
EP06716088A EP1855692B1 (en) 2005-02-28 2006-02-23 Compositions for treating skin diseases characterised by exudation of serum proteins

Publications (1)

Publication Number Publication Date
PL1855692T3 true PL1855692T3 (pl) 2012-05-31

Family

ID=36927638

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06716088T PL1855692T3 (pl) 2005-02-28 2006-02-23 Kompozycje do leczenia chorób skóry charakteryzujących się wysiękiem białek surowicy

Country Status (13)

Country Link
US (1) US8853195B2 (pl)
EP (2) EP1855692B1 (pl)
JP (2) JP5074929B2 (pl)
KR (1) KR100891595B1 (pl)
CN (1) CN101155589B (pl)
AT (1) ATE533495T1 (pl)
AU (1) AU2006217261B8 (pl)
BR (1) BRPI0608367A2 (pl)
CA (1) CA2599315C (pl)
ES (1) ES2377137T3 (pl)
PL (1) PL1855692T3 (pl)
RU (1) RU2403047C2 (pl)
WO (1) WO2006091033A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
WO2007142510A1 (en) * 2006-06-09 2007-12-13 Erasmus University Medical Center Rotterdam Modulation of the immune system by inositol phospholipids
KR101277630B1 (ko) * 2010-05-19 2013-06-21 주식회사 바이오피드 탈모방지 또는 육모 촉진용 조성물
KR101200392B1 (ko) 2010-07-12 2012-11-13 주식회사 바이오피드 혈액 단백질 삼출을 동반하는 피부질환들의 치료 및 증상완화용 패치
CN103483425B (zh) * 2013-08-23 2015-03-18 南京中医药大学 一种具有致痒作用的芋蛋白提取物及其制备方法和应用
WO2019009628A2 (ko) * 2017-07-07 2019-01-10 주식회사 리포바이오랩 화상 및 욕창의 완화 및 치료용 조성물
RU2691648C1 (ru) * 2018-05-28 2019-06-17 Олег Александрович Розенберг Способ получения сурфактанта из легких крупного рогатого скота

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS624215A (ja) 1985-07-01 1987-01-10 Shiseido Co Ltd 化粧料
JPH07116010B2 (ja) 1986-03-10 1995-12-13 株式会社コーセー 化粧料
JP3298867B2 (ja) 1988-06-20 2002-07-08 株式会社資生堂 透明組成物
DE69131163T2 (de) 1990-05-18 1999-12-23 Tokyo Tanabe Co., Ltd. Asthma heilmittel
DE4434629C1 (de) 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
DE69624137T2 (de) 1995-07-27 2003-06-18 Chisso Corp., Osaka Organosiliciumverbindungen, flüssigkristallzusammensetzungen und flüssigkristallanzeigeelemente
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
CA2277801C (en) 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
US20040228910A1 (en) * 1997-02-11 2004-11-18 Mse Pharmazeutika Gmbh Transdermal, oral and intravenous formulations of 2, 3-dimethoxy-5-methyl-6-decaprenyl-1, 4-benzoquinone
EP1007018B1 (de) * 1997-02-12 2003-10-08 MSE Pharmazeutika GmbH Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon inder behandlung von tinnitus
JP3783385B2 (ja) 1997-08-26 2006-06-07 キユーピー株式会社 リポソーム分散液の製造方法及びそれを用いた化粧料
AU1251999A (en) * 1997-12-03 1999-06-16 Britannia Pharmaceuticals Limited Improvements in medicaments for asthma treatment
US6320017B1 (en) * 1997-12-23 2001-11-20 Inex Pharmaceuticals Corp. Polyamide oligomers
US5989577A (en) 1998-03-02 1999-11-23 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
GB9912639D0 (en) * 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
WO2000030654A1 (en) 1998-11-26 2000-06-02 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
WO2001085136A2 (en) * 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
WO2002017878A1 (en) * 2000-09-01 2002-03-07 Marcus Larsson Lung surfactant compositions with dynamic swelling behaviour
RU2198670C1 (ru) 2002-02-19 2003-02-20 ООО "Биосурф" Способ получения сурфактанта из легких крупного рогатого скота
US20040009216A1 (en) * 2002-04-05 2004-01-15 Rodrigueza Wendi V. Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
JP2004131401A (ja) 2002-10-09 2004-04-30 Rohto Pharmaceut Co Ltd 皮膚化粧料
JP2004231544A (ja) 2003-01-29 2004-08-19 Nikko Chemical Co Ltd リン脂質のメラニン生成抑制剤としての利用
JP2004352643A (ja) 2003-05-29 2004-12-16 Kose Corp ゲル状化粧料
WO2004110450A1 (en) 2003-06-16 2004-12-23 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
TW200507879A (en) 2003-07-10 2005-03-01 Kose Corp Powdery compositions and skin preparation containing the same for external use
CN1560057A (zh) 2004-03-10 2005-01-05 山东师范大学 高纯度磷脂酰肌醇的制备方法
KR100891595B1 (ko) 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물

Also Published As

Publication number Publication date
HK1112592A1 (en) 2008-09-12
CA2599315C (en) 2013-01-22
KR100891595B1 (ko) 2009-04-03
CN101155589B (zh) 2011-06-15
AU2006217261B8 (en) 2010-01-28
CN101155589A (zh) 2008-04-02
WO2006091033A1 (en) 2006-08-31
US20090029950A1 (en) 2009-01-29
AU2006217261B2 (en) 2009-10-01
JP2008531682A (ja) 2008-08-14
ATE533495T1 (de) 2011-12-15
RU2007135881A (ru) 2009-04-10
EP2295025A1 (en) 2011-03-16
ES2377137T3 (es) 2012-03-22
US8853195B2 (en) 2014-10-07
EP1855692A1 (en) 2007-11-21
AU2006217261A1 (en) 2006-08-31
KR20060095141A (ko) 2006-08-31
JP2012188434A (ja) 2012-10-04
RU2403047C2 (ru) 2010-11-10
EP1855692B1 (en) 2011-11-16
JP5074929B2 (ja) 2012-11-14
BRPI0608367A2 (pt) 2009-12-29
CA2599315A1 (en) 2006-08-31
EP1855692A4 (en) 2008-09-10

Similar Documents

Publication Publication Date Title
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
BRPI0408388A (pt) compostos de benzopirano úteis no tratamento de patologias inflamatórias
TW200519075A (en) Novel compounds
EA200600414A1 (ru) ПРОИЗВОДНЫЕ БОРОНОВОЙ КИСЛОТЫ (ВАРИАНТЫ), ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, КОМПОЗИЦИЯ ДЛЯ ИНГИБИРОВАНИЯ АКТИВНОСТИ NF-kB И ДЕГРАДАЦИИ БЕЛКА И СПОСОБЫ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ (ВАРИАНТЫ)
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
WO2007070434A3 (en) Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
WO2008002571A3 (en) Human protein tyrosine phosphatase inhibitors and methods of use
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
TW200745003A (en) Novel compounds
BRPI0514448A (pt) derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias
WO2007098591A3 (en) Topical nail formulation
ATE555116T1 (de) Ahcy-hydrolasehemmer zur behandlung von hyperhomocysteinämie
WO2007052023A3 (en) Novel compounds
EA201591180A1 (ru) Составы ингибитора lfa-1
BR0308184A (pt) Composição oftálmica compreendendo ascomicina
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
PL1855692T3 (pl) Kompozycje do leczenia chorób skóry charakteryzujących się wysiękiem białek surowicy
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
WO2008036316A3 (en) Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005118636A3 (en) Tgf derepressors and uses related thereto